Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Hydrogen Water May Help Protect Against Early Menopause in Rat Study

Hydrogen-rich water treatment targets RT1-Db1 and RT1-Bb to alleviate premature ovarian failure in rats

Research hubs: Reproductive System · Endocrine System

This research was done in animals. Results in animals often don't carry over to people.

Scientific visualization of hydrogen therapy research for Hydrogen-rich water treatment targets RT1-Db1 and RT1-Bb to alleviate premature ovarian failure in rats
Evidence type
Animal study (rat)
Authors
Xiaoyin Meng, Shuai Zhang, Lu Zhao, Yingmei Wang
Journal
PeerJ
Year
2023
Study Type
Rat
Delivery
Water (Electrolysis)
Outcome
Positive
Peer Reviewed
Yes
Cited by
0 (OpenAlex, as of November 2026)
Country
China

TL;DR

Drinking hydrogen-rich water (HRW) may help to reduce the effects of premature ovarian failure (POF) in rats by improving hormone levels and ovarian health.

Key Finding

Hydrogen-rich water treatment restored hormone balance in rats with premature ovarian failure, increasing anti-mullerian hormone and estradiol while decreasing follicle-stimulating hormone, and identified RT1-Db1 and RT1-Bb as key molecular targets of this effect.

Summary

Researchers tested hydrogen-rich water on rats with premature ovarian failure (early loss of ovarian function) induced by a chemotherapy drug. The treatment improved hormone levels associated with ovarian health and reduced damage to ovarian tissue. The study used advanced protein analysis to identify two specific molecular targets (RT1-Db1 and RT1-Bb) through which hydrogen-rich water appeared to work.

Practical Takeaway

This is an early-stage animal study that suggests hydrogen-rich water may have protective effects on ovarian function, but it was conducted only in rats with chemotherapy-induced ovarian failure—not in women with naturally occurring premature ovarian failure. Much more research, including human trials, would be needed before any conclusions could be drawn about potential benefits for women. The specific molecular targets identified may help guide future research but do not yet translate to clinical recommendations.

Abstract (excerpt)

Background: Premature ovarian failure (POF) is defined as the cessation of ovarian function before the age of 40 years, imposing a significant health burden on patients. However, effective etiological therapy for POF is scarce. Thus, we aimed to explore the protective role and targets…

Read the full abstract on PubMed